OPC-21268, an orally effective, nonpeptide vasopressin V1 receptor antagonist

被引：0
|
作者：
机构：
来源：
| 1600年 / 252期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] OPC-21268 - A NONPEPTIDE ORALLY ACTIVE V1 VASOPRESSIN RECEPTOR ANTAGONIST
    BURRELL, LM
    PHILLIPS, PA
    RISVANIS, J
    STEPHENSON, J
    JOHNSTON, CI
    JOURNAL OF ENDOCRINOLOGY, 1992, 135 : P60 - P60
  • [2] OPC-21268 - AN ORALLY EFFECTIVE, NONPEPTIDE VASOPRESSIN V-1 ANTAGONIST
    KOHMOTO, O
    SERIZAWA, T
    CARDIOVASCULAR DRUG REVIEWS, 1993, 11 (03): : 271 - 282
  • [3] EFFECTS OF OPC-21268, AN ORALLY EFFECTIVE VASOPRESSIN V1 RECEPTOR ANTAGONIST IN HUMANS
    IMAIZUMI, T
    HARADA, S
    HIROOKA, Y
    MASAKI, H
    MOMOHARA, M
    TAKESHITA, A
    HYPERTENSION, 1992, 20 (01) : 54 - 58
  • [4] OPC-21268, an orally effective, nonpeptide arginine vasopressin V1 receptor antagonist reduces vasogenic brain edema
    Bemana, I
    Takahashi, E
    Nakamura, T
    Kuyama, H
    Nagao, S
    BRAIN EDEMA X, 1997, 70 : 194 - 197
  • [5] OPC-21268, AN ORALLY EFFECTIVE, NONPEPTIDE VASOPRESSIN-VI RECEPTOR ANTAGONIST
    YAMAMURA, Y
    OGAWA, H
    CHIHARA, T
    KONDO, K
    ONOGAWA, T
    NAKAMURA, S
    MORI, T
    TOMINAGA, M
    YABUUCHI, Y
    SCIENCE, 1991, 252 (5005) : 572 - 574
  • [6] Treatment of brain edema with a nonpeptide arginine vasopressin V1 receptor antagonist OPC-21268 in rats
    Bemana, I
    Nagao, S
    NEUROSURGERY, 1999, 44 (01) : 148 - 154
  • [7] CHARACTERIZATION OF A NOVEL NONPEPTIDE VASOPRESSIN V(1) RECEPTOR ANTAGONIST (OPC-21268) IN THE RAT
    BURRELL, LM
    PHILLIPS, PA
    STEPHENSON, J
    RISVANIS, J
    HUTCHINS, AM
    JOHNSTON, CI
    JOURNAL OF ENDOCRINOLOGY, 1993, 138 (02) : 259 - 266
  • [8] Effect of a nonpeptide vasopressin V1 antagonist(OPC-21268) on experimental accelerated focal glomerulosclerosis
    Kurihara, I
    Saito, T
    Obara, K
    Shoji, Y
    Hirai, M
    Imai, Y
    Abe, K
    NEPHRON, 1996, 73 (04): : 629 - 636
  • [9] Treatment of brain edema with a nonpeptide arginine vasopressin V1 receptor antagonist OPC-21268 in rats -: Comment
    Tator, CH
    NEUROSURGERY, 1999, 44 (01) : 154 - 154
  • [10] PHARMACOKINETICS, SAFETY, AND PHARMACOLOGICAL EFFECTS OF OPC-21268, A NONPEPTIDE ORALLY ACTIVE VASOPRESSIN-V1 RECEPTOR ANTAGONIST, IN HUMANS
    OHNISHI, A
    KO, Y
    FUJIHARA, H
    MIYAMOTO, G
    OKADA, K
    ODOMI, M
    JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 33 (03): : 230 - 238
12345